Ardelyx, Inc. (ARDX)
3.13
-0.08
(-2.49%)
USD |
NASDAQ |
Oct 21, 16:00
3.12
-0.01
(-0.32%)
After-Hours: 20:00
Ardelyx Net Income (Annual) : -61.60M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -61.60M |
| December 31, 2024 | -39.14M |
| December 31, 2023 | -66.07M |
| December 31, 2022 | -67.21M |
| December 31, 2021 | -158.16M |
| December 31, 2020 | -94.31M |
| December 31, 2019 | -94.94M |
| Date | Value |
|---|---|
| December 31, 2018 | -91.30M |
| December 31, 2017 | -64.34M |
| December 31, 2016 | -112.39M |
| December 31, 2015 | -29.62M |
| December 31, 2014 | -3.214M |
| December 31, 2013 | -6.564M |
| December 31, 2012 | -9.785M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Capricor Therapeutics, Inc. | -105.04M |
| REGENXBIO, Inc. | -193.88M |
| Compass Therapeutics, Inc. | -66.49M |
| ARS Pharmaceuticals, Inc. | -171.30M |
| Sionna Therapeutics, Inc. | -75.27M |